Successful Management of a Patient with Malignant Thyroid Teratoma

Guilherme Rabinowits1, Justine Barletta2, Lynette M Sholl2

  • 11 Medical Oncology, Dana-Farber Cancer Institute , Boston, Massachusetts.

Abstract

Insights

This study reports a rare aggressive thyroid teratoma with malignant transformation, successfully treated with chemotherapy and surgery. A DICER1 mutation was identified, suggesting its role in the tumor's development.

Area of Science:

  • Oncology
  • Genetics
  • Pathology

Background:

  • Malignant thyroid teratomas are rare and aggressive tumors with limited understanding of their development and treatment.
  • Primitive neuroectodermal tumor (PNET) transformation in thyroid teratomas is exceptionally uncommon.

Observation:

  • An adult woman presented with an aggressive thyroid teratoma exhibiting malignant transformation into a PNET.
  • Tumor and normal tissue sequencing identified a DICER1 c.5438A>G (p.E1813G) somatic mutation in 56% of sequencing reads.

Findings:

  • The identified DICER1 mutation is proposed as a driver event contributing to the malignant transformation.
  • This is the first report of DICER1 mutations in teratomas, though previously noted in PNETs.

Implications:

  • This case highlights a potential genetic mechanism in the malignant progression of thyroid teratomas.
  • The findings suggest that DICER1 mutations may play a role in PNET development within teratomas.
  • Successful management with neoadjuvant chemotherapy and surgery offers a potential therapeutic strategy for similar rare cases.

Related Concept Videos